GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Evoq Remedies Ltd (BOM:543500) » Definitions » Net Issuance of Preferred Stock

Evoq Remedies (BOM:543500) Net Issuance of Preferred Stock : ₹0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Evoq Remedies Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Evoq Remedies's net issuance of preferred for the six months ended in Mar. 2024 was ₹0.00 Mil. The number is 0, which means that Evoq Remedies has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Evoq Remedies's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00 Mil.

Evoq Remedies Net Issuance of Preferred Stock Historical Data

The historical data trend for Evoq Remedies's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evoq Remedies Net Issuance of Preferred Stock Chart

Evoq Remedies Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Issuance of Preferred Stock
Get a 7-Day Free Trial - - - - -

Evoq Remedies Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Net Issuance of Preferred Stock Get a 7-Day Free Trial Premium Member Only - - - - -

Evoq Remedies Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evoq Remedies Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Evoq Remedies's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Evoq Remedies (BOM:543500) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Evoq Remedies Ltd (BOM:543500) » Definitions » Net Issuance of Preferred Stock
Comparable Companies
NSE:MONOPHARMA BOM:543616 BOM:514330 BOM:543594 BOM:501477 LLY JNJ MRK ABBV XSWX:ROG LSE:AZN XSWX:NOVN PFE AMGN XPAR:SAN BMY GILD LSE:GSK TSE:4568 TSE:4519
Traded in Other Exchanges
N/A
Address
Science City Road, A-1106, Empire Business Hub, Near AUDA Water Tank, Sola, Ahmedabad, GJ, IND, 380060
Website
http://www.evoqremedies.com
Evoq Remedies Ltd is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, calcium, multivitamins, injections and others. It operates in a single segment that is Pharmaceutical Trading.

Evoq Remedies (BOM:543500) Headlines

No Headlines